Merck KGaA says earlier moves to localize manufacturing help ease Trump tariff impact news2025-03-06T15:26:35+00:00March 6th, 2025|Endpoints News|
China bans imports of Illumina’s DNA sequencers following US tariffsnews2025-03-04T20:24:53+00:00March 4th, 2025|Endpoints News|
Chinese ADC biotech lets Hong Kong IPO filing lapsenews2025-02-25T17:31:04+00:00February 25th, 2025|Endpoints News|
Pfizer wants in on Summit’s goal to beat Keytruda via ADC combosnews2025-02-24T12:18:40+00:00February 24th, 2025|Endpoints News|
How Keymed steered the China-to-US NewCo model in biotechnews2025-02-20T16:20:44+00:00February 20th, 2025|Endpoints News|
AstraZeneca buys FibroGen’s China unit for local control of anemia drugnews2025-02-20T12:35:47+00:00February 20th, 2025|Endpoints News|
FDA puts two Chinese API makers on import alert after failed inspectionsnews2025-02-11T18:24:55+00:00February 11th, 2025|Endpoints News|
Trump’s tariff impact likely ‘minimal’ for brand-name drugmakers news2025-02-10T18:22:08+00:00February 10th, 2025|Endpoints News|
Post-Hoc: China tensions both help and hurt Illuminanews2025-02-07T20:07:11+00:00February 7th, 2025|Endpoints News|
AstraZeneca offers some detail on China probe, reaffirms commitment to that marketnews2025-02-06T12:36:59+00:00February 6th, 2025|Endpoints News|
